- Home
- AEHL vs CLDI Comparison
AEHL vs CLDI Comparison
Compare AEHL & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEHL
- CLDI
- Stock Information
- Founded
- AEHL 1993
- CLDI 2014
- Country
- AEHL China
- CLDI United States
- Employees
- AEHL N/A
- CLDI N/A
- Industry
- AEHL Building Materials
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AEHL Industrials
- CLDI Health Care
- Exchange
- AEHL Nasdaq
- CLDI Nasdaq
- Market Cap
- AEHL 17.9M
- CLDI 20.2M
- IPO Year
- AEHL 2007
- CLDI N/A
- Fundamental
- Price
- AEHL $3.49
- CLDI $1.60
- Analyst Decision
- AEHL
- CLDI
- Analyst Count
- AEHL 0
- CLDI 0
- Target Price
- AEHL N/A
- CLDI N/A
- AVG Volume (30 Days)
- AEHL 83.2K
- CLDI 476.3K
- Earning Date
- AEHL 09-29-2025
- CLDI 08-08-2025
- Dividend Yield
- AEHL N/A
- CLDI N/A
- EPS Growth
- AEHL N/A
- CLDI N/A
- EPS
- AEHL N/A
- CLDI N/A
- Revenue
- AEHL $98,773,000.00
- CLDI N/A
- Revenue This Year
- AEHL N/A
- CLDI N/A
- Revenue Next Year
- AEHL N/A
- CLDI N/A
- P/E Ratio
- AEHL N/A
- CLDI N/A
- Revenue Growth
- AEHL 36.99
- CLDI N/A
- 52 Week Low
- AEHL $1.79
- CLDI $1.51
- 52 Week High
- AEHL $89.60
- CLDI $46.68
- Technical
- Relative Strength Index (RSI)
- AEHL 54.86
- CLDI 29.96
- Support Level
- AEHL $3.34
- CLDI $1.59
- Resistance Level
- AEHL $3.85
- CLDI $1.73
- Average True Range (ATR)
- AEHL 0.33
- CLDI 0.32
- MACD
- AEHL 0.05
- CLDI -0.07
- Stochastic Oscillator
- AEHL 62.75
- CLDI 2.28
About AEHL Antelope Enterprise Holdings Limited
Antelope Enterprise Holdings Ltd operates in two reportable operating segments: 1) business management consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting, and 2) natural gas power generation, which was in the initial development stage. The business of the Company is engaged in the PRC and U.S.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.